PHARMACY

DSN, Canadian Pharmacists Association hold groundbreaking event in Toronto
The event explored ways the two countries can learn from each other.
McKesson acquires Prism Vision Holdings
McKesson acquired an approximate 80% controlling interest in Prism Vision Holdings, an ophthalmology and retina management services provider, for about $850 million.

Aveva Drug Delivery Systems obtains FDA OK for generic lidocaine patch

Generic lidocaine 1.8% patch is a non-opioid topical treatment for post-herpetic neuralgia.
Glenmark launches vancomycin hydrochloride for injection

Vancomycin Hydrochloride for Injection had a market value of approximately $39.3 million for the 12-month period ending January 2025, per IQVIA.
Hy-Vee Health Exemplar Care opens new medical practices in Cedar Falls and Coralville

Health care memberships are available to employer groups, families and individual patients, providing unrestricted access to medical providers for one low monthly fee.
Digital tools play important role in patient experience, CVS Health Rx Report finds

The majority of Americans believe that in-person interactions with their pharmacy team are important and nearly half would likely switch their pharmacy if they were only able to interact with their pharmacist digitally.
Amneal launches Boruzu

Boruzu, a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma.
Organon acquires biosimilar to Acterma

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19.
Watch DSN: CVS Health, Emory Healthcare partner to expand primary care access

Dr. Creagh Milford, president of Retail Health at CVS Health, shares how the retailer's collaboration with Emory Healthcare aims to address the growing shortage of primary care providers by expanding services at MinuteClinics across Georgia.
Armas Pharmaceuticals reintroduces lidocaine jelly

Lidocaine jelly 2% is a topical anesthetic used in various medical applications, including urological and endoscopic procedures, to provide localized pain relief.